Category: biotech

.Merck &amp Co. has actually picked up possibilities on two Evaxion Biotech vaccine candidates, spending $3.2 million as well as swaying greater than $1 billion

.Merck &amp Co.’s long-running attempt to land a punch on tiny mobile lung cancer cells (SCLC) has acquired a little victory. The drugmaker’s Daiichi Sankyo-partnered

.A phase 3 trial of Daiichi Sankyo and also Merck &amp Co.’s HER3-directed antibody-drug conjugate (ADC) has actually hit its own main endpoint, improving plans

.Gilead Sciences as well as Merck &amp Co. have helped their once-weekly HIV mixture treatment past another landmark, connecting the beverage to sustained suppression of

.MBX has elaborated plans to absorb over $136 million from its IPO as the biotech looks to carry a prospective challenger to Ascendis Pharma’s uncommon

.MBX Biosciences has actually added to the latest flurry of IPO filings. The biotech, which submitted its own documentation full weeks after elevating $63.5 million

.Adhering to a bad showing for Lykos Therapeutics’ MDMA applicant for post-traumatic stress disorder at a latest FDA consultatory board conference, the other shoe has

.Psychopharmacology has actually drawn 3 short articles about midstage clinical trial data determining Lykos Therapies’ investigational MDMA applicant for handling trauma (POST-TRAUMATIC STRESS DISORDER). The

.Lykos Therapeutics might have dropped three-quarters of its own workers following the FDA’s being rejected of its own MDMA applicant for trauma, but the biotech’s

.Lundbeck is actually reducing guide worth of its own $250 thousand Abide Rehabs purchase in reaction to phase 1 information that activated an early end